Results 121 to 130 of about 50,123 (288)

AI Hallucinations in Tourism: How Errors Impact Consumer Trust and Recommendation Acceptance

open access: yesJournal of Consumer Behaviour, EarlyView.
ABSTRACT Generative artificial intelligence (GenAI) is quickly transforming travel planning; however, its outputs can include hallucinations, which are plausible yet false statements that can undermine user judgement. Eliminating hallucinations in GenAI technology is currently impossible.
Francisco Rejón‐Guardia   +2 more
wiley   +1 more source

Diagnostic challenges in shared delusional disorder (folie à deux). Case presentation

open access: diamond, 2021
Ligia Verșanu   +4 more
openalex   +1 more source

Risky or rigorous? Developing trustworthiness criteria for AI‐supported qualitative data analysis

open access: yes
Anatomical Sciences Education, EarlyView.
Michelle D. Lazarus   +4 more
wiley   +1 more source

Treatments for delusional disorder [PDF]

open access: green, 2015
Mike Skelton   +2 more
openalex   +1 more source

Postictal self‐removal of intracerebral electrodes during stereoelectroencephalography monitoring: A case series

open access: yesEpileptic Disorders, EarlyView.
Abstract Epilepsy surgery remains the most effective treatment for focal drug‐resistant epilepsy, and stereoelectroencephalography (SEEG) is increasingly used to define the epileptogenic‐zone network (EZN) and guide curative or palliative interventions.
Ionuț‐Flavius Bratu   +4 more
wiley   +1 more source

A call for ethical, equitable, and effective artificial intelligence to improve care for all people with epilepsy: A roadmap. A report by the ILAE Global Advocacy Council and Big Data Commission

open access: yesEpilepsia, EarlyView.
Abstract The artificial intelligence (AI) revolution is upon us. It will inevitably form a central component of epilepsy workflows and patient advocacy. Therefore, it behooves us as health care providers to ride the crest of this wave and guide its direction for the benefit of all people with epilepsy.
Colin B. Josephson   +13 more
wiley   +1 more source

Potential for use of Al/machine learning for pharmacovigilance: Is there a role for regulators?

open access: yes
British Journal of Clinical Pharmacology, EarlyView.
Christina Gao   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy